# Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

> **NCT00150904** · — · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 28 (actual)

## Conditions studied

- Hepatitis C
- HIV Infections

## Interventions

- **PROCEDURE:** venous blood puncture

## Key facts

- **NCT ID:** NCT00150904
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-09
- **Final completion:** 2009-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2009-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150904, "Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00150904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*